APA (7th ed.) Citation

Zhang, Y., Li, C., Du, M., Jiang, H., Luo, W., Tang, L., . . . Mei, H. (2023). Allogenic and autologous anti-CD7 CAR-T cell therapies in relapsed or refractory T-cell malignancies. Blood Cancer Journal, 13(1), 1-10. https://doi.org/10.1038/s41408-023-00822-w

Chicago Style (17th ed.) Citation

Zhang, Yinqiang, et al. "Allogenic and Autologous Anti-CD7 CAR-T Cell Therapies in Relapsed or Refractory T-cell Malignancies." Blood Cancer Journal 13, no. 1 (2023): 1-10. https://doi.org/10.1038/s41408-023-00822-w.

MLA (9th ed.) Citation

Zhang, Yinqiang, et al. "Allogenic and Autologous Anti-CD7 CAR-T Cell Therapies in Relapsed or Refractory T-cell Malignancies." Blood Cancer Journal, vol. 13, no. 1, 2023, pp. 1-10, https://doi.org/10.1038/s41408-023-00822-w.